CytrRx Corporation | CYTR - Equity Capital And Reserves

Cytrx reported $3.28M in Equity Capital and Reserves for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Equity Capital And Reserves Change
Bioline Rx BLRX:US USD 55.52M 1.04M
Brainstorm Cell Therapeutics BCLI:US USD 1.39M 6.46M
Celldex Therapeutics CLDX:US USD 326.2M 19.21M
Curis CRIS:US USD 46.55M 9.19M
Cytrx CYTR:US USD 3.28M 1.5M
Glaxosmithkline GSK:US GBP 10.6B 1.45B
Karyopharm Therapeutics KPTI:US USD -16656000 123.62M
Northwest Biotherapeutics NWBO:US USD -95104000 3.44M
Novartis NVS:US USD 59.34B 1.48B
Roche Holding ROG:VX 27.99B 2.8B
Seattle Genetics SGEN:US USD 2.8B 17.99M
Takeda 4502:JP JPY 6.18T 536.95B